NCT06908356: An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- State
- Under way
- Phase
- Phase 2
- People
- 50 planned
- Started
- 10 Jan 2025
- Primary completion
- Jul 2025
- Arms
- Open-label 30mg/day PRAX-628 for 8 weeks
- Results
- None posted
- 10 Jan 2025: Trial started
- 3 Apr 2025: Trial registered